[Screening and diagnostic assessment of ADHD in adults - risks associated with both underdiagnosis and overdiagnosis].

Autor: Hirvikoski T; docent, leg psykolog, specialist i neuropsykologi, Habilitering & hälsa, Region Stockholm; Center for Neurodevelopmental Disorders at Karolinska institutet (KIND), institutionen för kvinnors och barns hälsa, Karolinska institutet; Centrum för psykiatri-forskning (CPF), Stockholm., Billstedt E; professor, leg psykolog, Gillbergcentrum, institutionen för neuroveten-skap och fysiologi, Göteborgs universitet; Barn-neuropsykiatri/BNK, Sahlgrenska universitetssjukhuset., Lundström S; docent, leg psykolog, Gillberg-centrum, institutionen för neurovetenskap och fysiologi, Göteborgs universitet; Barn- och ungdomspsykiatrin, Region Skåne., Brar A
Jazyk: švédština
Zdroj: Lakartidningen [Lakartidningen] 2022 Feb 22; Vol. 119. Date of Electronic Publication: 2022 Feb 22.
Abstrakt: ADHD in adults is commonly associated with severe impairments in many major life activities, and an adequate diagnosis is a first step towards treatment and support. Negative consequences follow both underdiagnosis and overdiagnosis of adult ADHD, which can be confused with other psychiatric diagnoses and sometimes overlooked in people with high intellectual capacity, and in women in general. In a clinical practice, most physicians meet adults with ADHD - with or without a diagnosis - and therefore need competence in screening of ADHD in adults. Experienced clinicians conduct the consequent diagnostic assessment, to reduce risk of both underdiagnosis and overdiagnosis. Several national and international clinical guidelines summarize evidence-based practices for adults with ADHD. European Network Adult ADHD, ENAA, revised consensus statement recommends pharmacological treatment and psychoeducation as a first step after ADHD diagnosis in adulthood.
Databáze: MEDLINE